Athena Diagnostics

Worcester, United States Founded: 1988 • Age: 38 yrs Acquired By Quest Diagnostics
Diagnostic testing is offered for neurology, endocrinology, and nephrology.

About Athena Diagnostics

Athena Diagnostics is a Healthcare company based in Worcester (United States) founded in 1988, and was acquired by Quest Diagnostics in February 2011. Diagnostic testing is offered for neurology, endocrinology, and nephrology. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Diversified. Its legal entity is ATHENA DIAGNOSTICS INC. Its competitors include Foundation Medicine, Personalis and Lantern Pharma; 3 of its 3 listed competitors have raised funding.

Company details

Athena Diagnostics was established in 1988 in Worcester, United States. Diagnostic testing is focused on neurological, endocrine, and renal conditions. More than 400 tests are provided, including options for Alzheimers disease, muscular dystrophy, and other neuromuscular and developmental disorders. An intellectual property portfolio is maintained to support these areas of specialization.

Key Metrics

Funding Insights of Athena Diagnostics

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Athena Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2002Unspecified––
Valuation history

2 investors in total: 2 institutional.

Investors in Athena Diagnostics

Athena Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Quest Diagnostics and Windjammer Capital Investors.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments are managed from Newport Beach, United States.
windjammercapital.comNewport Beach, United States
Integrated diagnostic and IT services are provided to healthcare organizations.
1967questdiagnostics.comMadison, United States
Premium access

Investor details for Athena Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Athena Diagnostics

5 people are tracked at Athena Diagnostics (1 in leadership, 4 in board & advisors).

NameRoleGroup
Robert Flaherty
CEOLeadership
Dev Batish
DirectorBoard & advisors
Thomas Mullen
Scientific DirectorBoard & advisors
Zhenyuan Wang
DirectorBoard & advisors
Michael Racke
Neurology Medical DirectorBoard & advisors
Premium access

Complete people profiles for Athena Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Athena Diagnostics

3 dated milestones of Athena Diagnostics across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Athena Diagnostics is founded.
  2. Funding First funding round.
  3. Exit Acquired by Quest Diagnostics.

Competitors of Athena Diagnostics

Athena Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Foundation Medicine, Personalis and Lantern Pharma.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
foundationmedicine.com2010Cambridge, United States$96.5M1,707
Genomics-based diagnostic tests for cancer are provided.
personalis.com2011Menlo Park, United States$87.3M310
Genomic sequencing and diagnosis software is provided for healthcare.
lanternpharma.com2013Dallas, United States$7.12M23
Drug and companion diagnostics for multi-drug resistant cancers are developed.
Premium access

Detailed competitors of Athena Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Athena Diagnostics

The website of Athena Diagnostics (athenadiagnostics.com) receives about 9.1K visits a month.

  • Monthly visits
    9.1K

    ▼ 15.3% vs previous month

Similar websites

Websites whose visitors overlap most with Athena Diagnostics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
aruplab.com
100%
138.9K#300,732View details
enterolab.com
enterolab.com
74%
–
ambrygen.com
73%
189.2K#206,714View details
questdiagnostics.com
71%
14.4M#2,905View details
athenahealth.com
64%
33.3M#983View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 11 similar websites and full traffic analytics for Athena Diagnostics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Athena Diagnostics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Athena Diagnostics

Premium access

Complete news archive for Athena Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Athena Diagnostics

Athena Diagnostics was founded in 1988 and raised its 1st funding round 14 years after it was founded.

Athena Diagnostics is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.

Athena Diagnostics was established in 1988 in Worcester, United States. Diagnostic testing is focused on neurological, endocrine, and renal conditions. More than 400 tests are provided, including options for Alzheimers disease, muscular dystrophy, and other neuromuscular and developmental disorders. An intellectual property portfolio is maintained to support these areas of specialization.

Athena Diagnostics's top competitors include Foundation Medicine, Personalis and Lantern Pharma.

Athena Diagnostics has 2 investors. Key investors include Quest Diagnostics, and Windjammer Capital Investors.

Athena Diagnostics operates through Athena Diagnostics Inc.

Yes. Athena Diagnostics was acquired by Quest Diagnostics in February 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available